Ignite Creation Date:
2025-12-25 @ 1:47 AM
Ignite Modification Date:
2026-01-06 @ 2:33 PM
Study NCT ID:
NCT03383094
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-07
First Post:
2017-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
Sponsor:
Loren Mell, MD
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Head and Neck Squamous Cell Carcinoma | View |
| None | Cancer | View |
| None | Cancer of Head and Neck | View |
| None | Cancer, Advanced | View |
| None | Cancer, Metastatic | View |
| None | Tumor | View |
| None | Tumor Recurrence | View |
| None | Tumor Neck | View |
| None | Tumor Metastasis | View |
| None | Oral Cancer | View |
| None | Oropharyngeal Cancer | View |
| None | Oropharynx Cancer | View |
| None | Oropharynx Cancer, Stage III | View |
| None | Oropharynx Cancer, Recurrent | View |
| None | Oropharynx Cancer, Metastatic | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | cancer | View |
| None | Head and Neck | View |
| None | Pembrolizumab | View |
| None | Cisplatin | View |
| None | Radiotherapy | View |
| None | Head and Neck Squamous Cell Carcinoma | View |
| None | p16+ | View |
| None | immunotherapy | View |
| None | pd-1 | View |
| None | chemotherapy | View |
| None | T1 | View |
| None | T2 | View |
| None | T3 | View |
| None | N2 | View |
| None | M0 | View |
| None | T4 | View |
| None | N3 | View |
| None | N1 | View |